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Abstract: Epidemiological studies comparing typical Western and traditional Eastern lifestyles indicate that dietary intake of soy-
derived phytoestrogens, including genistein, daidzein, and equol, may have signifi cant health protective eff ects on 
hormone-dependent cancers, osteoporosis and cardiovascular diseases. Phytoestrogens have been demonstrated to 
exert varying eff ects depending on tissue, endogenous hormone concentrations, and receptor types. Thus, a detailed 
understanding of the biodistribution and bioavailability of specifi c phytoestrogens is required in order to predict 
the subsequent biologic activities. In this study we aimed to investigate the cellular uptake of these soy-derived 
phytoestrogens in diff erent cell types, including the mammary MCF-7/6 and MDAB-MB 231 cell lines, the ovarian 
Ishikawa Var-I cell lines and in murine adipocyte clusters. Furthermore, the biodistribution between serum and cell 
fraction was also investigated in human whole blood. Equol generally shows a higher cellular uptake when compared 
with genistein and daidzein. Therefore, equol may be more potent with respect to its relative bioactivity, which is 
corroborated by the observations of specifi c health eff ects associated with the equol-producer phenotype. 
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INTRODUCTION
Phytoestrogens are mostly non-steroidal polyphenolic 
plant-derived compounds that functionally mimic the 
activity of the human estrogen, estradiol-17β [1]. The most 
important phytoestrogens in the human diet are the soy-
derived isoﬂ avones, daidzein and genistein. In addition, the 
gastrointestinal microﬂ ora can further metabolize daidzein 
into the more potent estrogen equol, but this biotransformation 
is subject to a high inter-individual variability [2]. An increasing 
number of epidemiological and experimental studies suggest 
that the consumption of phytoestrogen-rich diets may have 
protective eﬀ ects on estrogen-related conditions, such as 
menopausal symptoms [3], and estrogen-related diseases, 
such as prostate and breast cancers [4, 5], osteoporosis [6], 
and cardiovascular diseases [7]. However, consumption of 
too high levels of these compounds may not be without risk . 
Phytoestrogens have been demonstrated to exert 
varying eﬀ ects depending on tissue, endogenous hormone 
concentrations, and receptor type(s). Thus, a detailed 
understanding of the biodistribution and bioavailability of 
speciﬁ c phytoestrogens is required in order to predict the 
subsequent biologic activities. In this study, we aimed to 
investigate the cellular uptakes of genistein, daidzein, and 
equol in diﬀ erent cell types. By adding the compounds 
either individually or combined, competition eﬀ ects for the 
estrogen receptors were investigated. Furthermore, the role 
of the estrogen receptor was probed by adding a pure estrogen 
receptor antagonist (ICI 182,780) together with the soy-
derived phytoestrogens, in addition to studying the cellular 
uptake of the compounds in an estrogen receptor-negative 
cell line, MDA-MB 231. As isoﬂ avones and derivatives are 
partly hydrophobic in nature, and as estrogen receptors are 
also present in adipose tissue [8], we speculated whether the 
cellular uptake of isoﬂ avones in adipocytes would diﬀ er from 
that found in the human mammary and uterine carcinoma 
cell lines. It has, indeed, been reported that environmental 
estrogens such as polychlorinated bifenyls (PCBs) can 
accumulate in human adipose tissue [9].
MATERIALS AND METHODS
MCF-7/6 cells. MCF-7/6 cells were obtained from Dr. H. 
Rochefort (Unite d’Endocrinologie Cellulaire et Moléculaire, 
Montpellier, France) and are variants of the originally derived 
MCF-7 cells (from a pleural eﬀ usion of a metastasised 
mammary adenocarcinoma [10]). These cells possess fully 
characterised estrogen receptors, and several cellular activities, 
such as proliferation and migration in vitro, are modulated by 
17β-estradiol and other ligands of the steroid/thyroid receptor 
superfamily [11]. The cells were grown and cultured in a 
(50/50, v:v) mixture of DMEM Ham-12, supplemented with 
100 IU/ml penicillin (Gibco, Merelbeke, Belgium), 100 μg/ml 
streptomycin (Gibco), 2.5 μg/ml Fungizone® (Bristol-Myers 
Squibb, Brussels, Belgium), and 10% foetal bovine serum 
(FBS) in 6-well plates (Nunc, Roskilde, Denmark) in a water-
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saturated atmosphere of 10% CO2 in air at 37°C. On the day 
of assay (near conﬂ uency), the cell medium was aspirated, 
the wells were washed twice with phosphate-buﬀ ered saline 
(PBS), and the test compounds were added to 4 ml of fresh 
medium containing serum (in duplicate). 0.1 M stock solutions 
of genistein, daidzein, and equol in DMSO were diluted in 
DMEM/Ham F12 to yield a ﬁ nal concentration of 10 μM 
before being added to the 6-well plates containing the cells. 
The compounds were either added individually or combined. 
The ﬁ nal dilution of DMSO in the cell medium did not exceed 
1/1000. ICI 182,780 was added at a ﬁ nal concentration of 
10-8 M in the assay medium 10 min prior to test compounds 
in order to avoid competition. Incubation times ranged from 
1 h to 24 h.
After the end of incubation, the medium of each well was 
removed and transferred into falcon tubes. The wells were 
washed twice with DMEM/Ham F12 and each wash was 
added to the respective falcon tube. 90 μl internal standard 
(8 mg 4-hydroxy benzophenone (4-HBPH) in 100 ml ethyl 
acetate), together with 6 ml ethyl acetate, was added to each 
falcon tube and the soy-derived phytoestrogens extracted. 
The extract was dried under a steady stream of nitrogen and 
the residue redissolved in 150 μl water:methanol (50/50, v:
v) containing 0.05% formic acid. The samples were analysed 
using HPLC. The results are expressed as percentage uptake. 
Total lysates were prepared by washing the cells 3 times with 
PBSD+ (phosphate-buﬀ ered saline with Ca2+), the remaining 
ﬂ uid was removed, 100 μl buﬀ er (9 M urea) added, and the cells 
incubated for 30 min at 37°C. The cells were then scraped from 
the plastic using a cell-scraper and 900 μl buﬀ er was added 
again. The cells were suspended and the lysates extracted 
with 90 μl internal standard (8 mg 4-HBPH in 100 μl ethyl 
acetate) and 2 ml ethyl acetate. The extract was dried under 
a steady stream of nitrogen and the residue redissolved in 150 
μl water:methanol (50/50, v:v) containing 0.05% formic acid. 
The samples were analysed using HPLC. Unless otherwise 
indicated, all sera, culture media and reagents were from 
Sigma-Aldrich (Bornem, Belgium).
MDA-MB 231 cells. Semi-conﬂ uent monolayers of MDA-
MB 231 cells (a cell line originating from pleural eﬀ usion of a 
breast adenocarcinoma [12]) were obtained from the American 
Type Culture Collection (ATCC, HTB26). The cells were 
grown and cultured in Leibovitz’s L-15 medium (Invitrogen™ 
Life Technologies, Merelbeke, Belgium), supplemented 
with 11.6 ml (streptomycin + penicillin) (Gibco), 300 μl 
Fungizone® (Bristol-Myers Squibb, Brussels, Belgium), and 
56 ml foetal bovine serum (FBS) per liter in 6-well plates 
(Nunc, Roskilde, Denmark) in air at 37°C. On the day of assay 
(near-conﬂ uency), the cell medium was aspirated oﬀ , the wells 
were washed twice with PBS, and the test compounds added 
in 4 ml of fresh medium (in duplicate). 0.01 M stock solutions 
of genistein, daidzein, and equol in DMSO, respectively, were 
diluted in DMEM/Ham F12 to yield a ﬁ nal concentration 
of 10 μM before being added to the 6-well plates containing 
the cells. The ﬁ nal dilution of DMSO in the cell medium did 
not exceed 1/1000. The 6-well plate was incubated for 1 h at 
37°C. After incubation, the medium of each well was taken 
oﬀ  and transferred into falcon tubes. The wells were washed 
twice with DMEM/Ham F12 and each wash was added to the 
respective falcon tube. 90 μl internal standard (8 mg 4-HBPH 
in 100 ml ethyl acetate), together with 6 ml ethyl acetate, was 
added to each falcon tube and the soy-derived phytoestrogens 
were extracted. The extract was dried under a steady stream of 
nitrogen and the residue redissolved in 150 μl water:methanol 
(50:50, v:v) containing 0.05% formic acid. The samples were 
analysed using HPLC.
Ishikawa Var-1 cells. The cells were grown and cultured in 
a (50/50, v:v) mixture of DMEM/Ham-12, supplemented with 
100 IU/ml penicillin (Gibco, Merelbeke, Belgium), 100 μg/ml 
streptomycin (Gibco), and 5% foetal bovine serum (FBS) in 75 
cm² polyethylene ﬂ asks (Nunc, Roskilde, Denmark) in a water-
saturated atmosphere of 5% CO2 in air at 37°C. Cells were 
plated at 1.5 x 106 cells/75 cm2 ﬂ ask and passaged twice weekly. 
Twenty-four hours before the start of an experiment, near-
conﬂ uent cells were harvested with 0.25% trypsin and plated 
in 6-well plates in an estrogen-free basal medium (EFBM), 
containing phenol red-free Ham F12 and 5% charcoal-stripped 
FBS. The cells were plated in 6-well plates (Nunc, Roskilde, 
Denmark) in a 95% humidiﬁ ed atmosphere at 37°C.
On the day of assay (near conﬂ uency), the cell medium was 
aspirated oﬀ , the wells were washed twice with PBS, and the 
test compounds added in 4 ml of fresh EFBM (in duplicate). 
0.1 mM stock solutions of genistein, daidzein, and equol in 
ethanol were diluted to concentrations of 10 μM in medium 
before being added to the 6-well plates containing the cells. 
Compounds were added either individually or combined. 
Stock solutions provided a ﬁ nal dilution in the cell medium 
of 1/1000. Incubation times ranged from 1 h – 4.5 h. The cell 
medium and the medium from the 2 washes were transferred 
to falcon tubes and extracted with 90 μl internal standard (8 
mg 4-HBPH in 100 ml ethyl acetate) and 4 ml ethyl acetate. 
The extract was dried under a steady stream of nitrogen and 
the residue redissolved in 150 μl water:methanol (50/50, v:v) 
containing 0.05% formic acid. The samples were analysed 
using HPLC. The results are expressed as percentage uptake, or, 
when both cellular and medium concentrations were available, 
as concentration (μM or nM). Any remaining phytoestrogens 
in the 6-well plates were extracted by adding 90 μl internal 
standard (8 mg 4-HBPH in 100 ml methanol) and 2 ml 
methanol to each well. The 6-well plates were transferred to 
an orbital shaker for 1 h and methanol evaporated to dryness 
under a steady stream of nitrogen. The residue was redissolved 
in 150 μl water:methanol (50/50, v:v) containing 0.05% formic 
acid. The samples were analysed using HPLC. The results are 
expressed as percentage uptake.
Murine adipocyte clusters. The treatment of adipose 
tissue was a modiﬁ ed version of that described by Pedersen 
et al. [8] and Reedy et al. [13]. Adipocytes, after being adhered 
to the tissue culture ﬂ ask following isolation, are almost lipid-
free and demonstrate a ﬁ broblast-like morphology. Exposure 
to an adipogenic agent for about 6 days is then necessary for 
the cells to re-accumulate lipid droplets. Adipose conversion 
is completed after approximately 16 days with 50-70% of the 
cells acquiring the adipocyte phenotype morphology [8]. Thus, 
due to the relatively long and laborious process of cultivating 
mature adipocytes in vitro, isolated adipocyte clusters rather 
than cells were chosen for the experiments. Adipose tissue 
was obtained from male white mice (strain TO, Harlan OLAC, 
Bicester, UK) and, typically, 1.6 g adipose tissue from the testis 
region could be extracted from one mouse. The adipose tissue 
was extracted from the mice using a scalpel, a pair of tweezers, 
and a pair of scissors. Great care was taken to dissect away under 
a microscope ﬁ brous tissue, blood vessels, and other interfering 
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fragments. The tissue was placed directly in PBS containing 
collagenase (10 μg/ml) and then minced into fragments that 
were placed in 6-well plates. Five PBS tablets, 20 g bovine 
serum albumin (BSA), and 10 mg collagenase were added to 
1 l of water into a sterile conical ﬂ ask and the ﬂ ask placed on 
a magnetic stirrer for ca.1 h. The pH was adjusted to 7.4 by 
adding hydrochloric acid or NaOH. Adipocytes were grown 
and cultured in (50/50, v:v) mixture of DMEM/Ham F12 
supplemented with 100 IU/ml penicillin (Gibco, Merelbeke, 
Belgium), 100 μg/ml streptomycin (Gibco), 10% foetal calf 
serum (FCS) and 1.65% 1 mM HEPES buﬀ er. 
To test the experimental design and conditions, eppendorf 
tubes with murine adipocyte clusters were incubated with 
50 μl tritiated 17β-estradiol (3H-E2) at a concentration of 600 
nM in 5 ml charcoal-stripped DMEM, with an incubation 
time of 30 min at 37°C in a 95% humidiﬁ ed atmosphere. An 
eppendorf tube containing 3H-E2 in medium was included as 
a control. After incubation, the clusters were washed with 
PBS and the medium, and together with PBS, was analysed 
using a beta counter (Beckman LS 6000IC Liquid Scintillation 
Counter, Beckman, Fullerton, California, USA) (10 min 
counts). The diﬀ erence in the total amount of 3H-E2 added 
to the adipocyte clusters and the amount recovered was used 
as the adipocyte cellular uptake. 
The same experiment was repeated, but with a combined 
addition of genistein, daidzein, and equol at ﬁ nal concentra-
tions of 10 μM in DMEM (40 μl were added to the wells, 
respectively, and left to evaporate before 4 ml of medium 
was added). In addition, one 6-well plate was incubated 
with a combined solution of genistein, daidzein, and equol 
at a ﬁ nal concentration of 10 μM in order to investigate the 
reproducibility in uptake across the wells. The incubation 
time for all these plates was set to 30 min, after which the 
medium was removed and added to small falcon tubes. The 
clusters were washed with PBS, which was also added to the 
corresponding falcon tubes. The medium, together with PBS 
from each well, was extracted with 90 μl internal standard 
(8 mg 4-HBPH in ethyl acetate) and 7 ml ethyl acetate. The 
solvent was evaporated under a gentle stream of nitrogen and 
the residues redissolved in 150 μl water:methanol (50/50, v:v) 
containing 0.05% formic acid. Concentrations of genistein, 
daidzein, and equol were analysed using HPLC.
To determine whether the cellular uptake of soy-phyto-
estrogens was time-dependent, and whether co-incubation of 
the 3 compounds together would cause competition eﬀ ects for 
the ERs, genistein, daidzein, and equol were added separately 
to the wells and the solvent was evaporated before the medium 
was added. The ﬁ nal concentration of each compound in each 
well was 10 μM. All experiments were carried out in duplicate 
in 6-well plates. Incubation times were 10, 30, 90, and 270 min, 
respectively, at 37°C in a 95% humidiﬁ ed atmosphere. Next, 
the medium was removed, the cells were washed with PBS, 
and the medium and PBS for each well extracted with 90 μl 
internal standard (8 mg 4-HBPH in ethyl acetate) and 7 ml 
ethyl acetate. The solvent was evaporated under a gentle 
stream of nitrogen and the residues redissolved in 150 μl 
water:methanol (50/50, v:v) containing 0.05% formic acid. 
The samples were analysed using HPLC.
The murine adipocyte clusters were kept in eppendorf tubes 
and frozen at -80°C. After thawing at room temperature, the 
adipocyte clusters were carefully weighed and extracted with 
90 μl internal standard (8 mg 4-HBPH in 100 ml ethyl acetate) 
and 5 ml ethyl acetate. The solvent was evaporated under a 
gentle stream of nitrogen and the residues redissolved in 150 μl 
water:methanol (50/50, v:v) containing 0.05% formic acid.
The samples were analysed using HPLC.
Controls. For all experiments, the solutions of genistein, 
daidzein, and equol were added to the respective cell media 
and extracted. The concentration of each compound, as 
measured by HPLC, was set to 100% and considered to be 
the control concentration. All cellular uptake measurements, 
both from cells and corresponding media, were calculated 
against these values.
Human blood fractions. A blood sample from a female 
volunteer was taken on 2 separate occasions. The ﬁ rst sampling 
occurred 24 h after 500 ml soy milk intake, whereas the other 
sampling took place 8 h after intake of 3 EB605 tablets (Eko-Bio, 
Eede, The Netherlands, containing 100 mg genistein/genistin, 
37 mg daidzein/daidzin, and 15 mg glycitein/glycitin). The 
blood was immediately centrifuged at 3,000 g for 10 min and 
the serum removed. 1 ml of each fraction, i.e. from both the 
serum and the cellular fraction of the blood, was extracted 
with 90 μl internal standard (8 mg 4-HBPH in 100 ml ethyl 
acetate) and 4 ml of ethyl acetate. The extract was evaporated 
to dryness under a steady stream of nitrogen. The residue was 
redissolved in 150 μl water:methanol (50:50, v:v) containing 
0.05% formic acid. The samples were analysed using HPLC. 
The results are expressed as μmol/ml.
HPLC-analysis. The HPLC-analyses were carried out using 
a Waters 2690 Separations HPLC module equipped with a 
996 photodiode array detector (Waters, Brussels, Belgium). 
Chromatographic processing was carried out using Waters 
Millennium version 3.2 software. The reversed-phase silica 
column was an XTerraTM MS C18 5 μm, 4.6 × 250 mm (Waters, 
Brussels, Belgium). Analyses were carried out using the 
following gradient: 0-20 min: 90% A in B, 20-27min: 70% A 
in B, 27-30 min: 90%, with solvent A being water and solvent 
B being acetonitrile both acidiﬁ ed with 0.05% formic acid. 
The ﬂ ow rate was 1.5 ml /min. The injection volume was 20 μl. 
Ultraviolet detection was typically conducted at 254 nm. 
Statistical methodology. All experiments were carried out 
in triplicate; means and SD were calculated. The statistical 
package SPSS for Windows version 15.0 (Chicago, IL, USA) 
was used and results were considered signiﬁ cant when P<0.05. 
The Kolmogorov-Smirnov and Levene’s test showed that all 
data were normally distributed and had equal variances, 
respectively. Therefore, all comparisons were carried using 
the 1-way ANOVA with Bonferroni error protection and the 
paired Student’s t-test.
RESULTS
Genistein, daidzein, and equol were added at a concentration 
of 10 μM to the medium of MCF-7/6 cells. Cellular uptake was 
estimated by measuring the remaining concentrations of each 
compound in the medium after an incubation period of 1 h 
(Figure 1). For genistein and daidzein, 50-60% of the original 
level was found, whereas for equol only 15% could be retrieved. 
On the other hand, the concentrations of the respective soy-
derived phytoestrogens in the corresponding cell lysates were 
below the level of detection; therefore, the levels lost in the 
medium could not be accounted for.
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Table 1 Uptake of 3H-E2 in murine adipocyte clusters. Incubation 
of medium only (control) and medium containing murine adipocyte 
clusters with 3H-E2. The experiment was carried out once.
Sample Mean counts per min (cpm)
 of β-radiation
Medium (control) 188,457
Medium from murine adipocyte clusters (n = 2) 94,393
To further elucidate the cellular uptake of soy-derived 
phytoestrogens and the role of the estrogen receptors, genistein, 
daidzein, and equol, at a concentration of 10 μM, were added 
to MDA MB 231 cells. This cell line exhibits no functional 
estrogen receptors, and therefore provided a valuable tool 
for this investigation. Highly analogous results were found 
for the remaining levels of all phytoestrogens in the medium 
after an incubation period of 1h (results not shown). However, 
in the corresponding cell lysates, a small amount of equol 
equaling 0.3% of the administered dosage could be retrieved. 
The addition of anti-estrogen ICI 182,780 (10 nM) in either 
type of cell did not show any impact on the results.
The cellular uptake of genistein, daidzein, and equol was 
also investigated in the Ishikawa Var-1 cell line (Figure 2), 
both in serum-containing and in serum-free medium. After 
incubation for 1h all phytoestrogens were present in the 
medium at levels of 40-50% of the original concentration. In 
contrast to the results found with the mammary carcinoma 
cell lines, equol showed a similar response to genistein and 
daidzein. No signiﬁ cant diﬀ erences were noticed between the 
presence or absence of serum for both genistein and daidzein. 
However, signiﬁ cantly less equol could be retrieved in the 
medium after incubation in the presence of serum (P<0.05). 
Next, the cellular uptake of phytoestrogens in murine 
adipocyte clusters was investigated. First, as a control, the 
uptake of 17β-estradiol was investigated using a tritium labeled 
probe. The mean number of counts of 3H-E2 in medium from 
murine adipocyte clusters was found to be lower than the 
counts in medium only, indicating cellular uptake of estrogens 
in adipocytes (Table 1).
Figure 1 Recovery (%) of genistein, daidzein, and equol (10 μM) in medium of 
MCF-7/6 cells after 1 h of incubation (n = 6, mean ± SD).
Figure 2 Recovery (%) of genistein, daidzein, and equol (10 μM) in medium of 
Ishikawa Var-1 cells. Cells were kept in respective media for 24 h before the start of 
the experiment to establish possible eff ects of serum proteins on cellular uptake 
of these compounds. The incubation period was 0.5 h (n = 6, mean ± SD).
* Signifi cantly diff erent at p< 0.05.
After dosing genistein, daidzein and equol to murine 
adipocyte clusters in medium, increased cellular concentrations 
of genistein, daidzein, and equol in murine adipocytes were 
determined with increased incubation times (Figure 3). 
These observations are in line with a general decrease in 
concentrations in the medium. Cellular uptake of equol was 
not evident until 90 min, but increased further up to 270 
min. 
Finally, the distribution of genistein, daidzein, and equol 
was investigated in cellular and serum fractions of human 
blood 24 h after intake of 0.5 l soymilk, and 8 h after intake 
of 1 soy tablet EB 605. At 24 h after soymilk intake, only equol 
could be detected with an approximate 2:1 ratio in serum and 
cell fraction, respectively, while, 8 h after soy tablet intake, all 
compounds could be detected in both the serum and cellular 
fractions in blood (Figure 4). Equol was present in very small 
concentrations, while genistein and daidzein were equally 
Figure 3 Recovery (%) of genistein, daidzein, and equol (10 μM) in a) murine adipocyte clusters, b) in medium of murine adipocytes over time (n = 4, mean ± SD).
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distributed both in serum and in the cellular fractions with 
a serum/cell fraction ratio of 10.
DISCUSSION
Cellular uptakes of genistein, daidzein, and equol in 
MCF-7/6 cells, Ishikawa Var-1 cells, MDA-MB 231 cells, and 
murine adipocyte cells were examined by measuring the 
respective concentrations in the medium and, if possible, in 
the cells. Furthermore, the distribution of these soy-derived 
phytoestrogens in the serum and cell fraction of whole human 
blood was also investigated. After incubation with MCF -
7/6 cells, genistein and daidzein were retrieved from the 
medium in signiﬁ cantly higher concentrations than equol. 
This suggests a high and preferential uptake of equol by the 
MCF-7/6 cells. The discrepancy between the phytoestrogen 
concentrations in the medium and those in the cell fractions 
(below detection level) may suggest either extensive loss during 
the washing step or rapid biotransformation. Considering the 
relatively large wash volume, it is likely that some or all of the 
phytoestrogens originally present in the cells were removed 
during washing. When all compounds were co-incubated at 
10 μM in the medium, a highly analogous pattern of uptake 
was observed (results not shown). Furthermore, the cellular 
uptake of genistein, daidzein, and equol (10 μM) in MCF-7/6 
cells in the presence of ICI 182,780 (10 nM) was investigated 
(results not shown). Interestingly, the uptake of the soy-derived 
phytoestrogens in MCF-7/6 cells was largely unaﬀ ected by the 
addition of ICI 182,780, suggesting that estrogen receptors 
are not involved in the cellular uptake mechanism. This is 
also substantiated by the higher aﬃ  nities of genistein for 
both ERα and ERβ, compared with that of daidzein, which, 
in that case, should lead to a higher uptake of genistein. Nagel 
et al. suggested that some compounds with low aﬃ  nity for 
the estrogen receptor require longer incubations to reach 
steady-state conditions [14]. They also found that estrogen 
receptor down-regulation in MCF-7/6 cells occurred between 
1–8 h, but the concentrations of estrogen receptors did not 
change further between 8–18 h. However, during initial 
experiments to optimize the incubation times, no signiﬁ cant 
diﬀ erences in isoﬂ avone uptake over time were observed for 
the tested cells. Further conﬁ rmation for the non-involvement 
of estrogen receptors was obtained with MDA-MB 231 cells. 
These cells are derived from a mammary adenocarcinoma 
cell line and the 231 variant lacks both estrogen receptors. 
The results were highly analogous to those obtained with 
MCF-7/6 cells. Interestingly, the results with Ishikawa Var-I 
cell lines diﬀ ered signiﬁ cantly from the mammary cell lines. 
For all soy-derived phytoestrogens ca 50% of the applied 
concentration could be retrieved from the medium, both in 
serum-free and serum-added conditions. Both serum albumin 
and sex hormone binding globulin (SHBG), that can bind 
the studied phytoestrogens, are present in charcoal-stripped 
serum; however signiﬁ cant amounts of SHBG are denatured 
during heat inactivation of the serum (the ﬁ nal concentration 
in 10% serum is < 3 nmol/l). It is indicated, therefore, that, 
at least under the conditions described here, the presence or 
absence of these proteins will not greatly inﬂ uence cellular 
uptake. As such, only slightly less equol could be found after 
incubation in the presence of serum. 
Extensive metabolism of particular phytoestrogens has 
been observed in MCF-7 and other mammary cancer cell 
lines, and this metabolism seems to diﬀ er depending on the 
cell lines [15]. Nagel et al. found that after incubation with 
MCF-7 cells in serum-free medium for 18 h, genistein and 
equol were not metabolised, whereas only 15% coumestrol 
remained after incubation in the serum-free medium [14]. 
In serum, genistein and coumestrol were metabolised to 
a similar extent, 53 and 68%, respectively. Peterson et al. 
showed that genistein was taken up and concentrated 20-fold 
above the medium concentration within human mammary 
epithelial cells [16]. Growth inhibition of various isoﬂ avones 
in ZR-75-1, BT-20, T47D and MCF-7 cells was studied and it 
was found that the latter 2 cell lines produced hydroxylated 
and methylated metabolites of genistein and biochanin A, 
whereas the other cell lines did not. Peterson et al. further 
hypothesised that the metabolism may render more active 
forms of genistein (and biochanin A) in human breast cancer 
cells [15]. At a genistein concentration of 3.7 μM, they found 
a substantial conversion (89–100%) of genistein into a more 
polar product in each of the cell lines. However, for higher 
concentrations of genistein, great diﬀ erences between the 
metabolites from each of the cell lines were observed. This is 
Figure 4 Concentrations of genistein, daidzein, and equol (10 μM) in serum and cells after soy isofl avone intake. a) Blood was taken from a female volunteer 24 h 
after intake of 0.5 l soy milk, b) blood was taken from a female volunteer 8 h after intake of a soy tablet (300 mg genistein/genistin, 111 mg daidzein/daidzin, 45 mg 
glycitein/glycitin) (Mean ± SD of 3 injections).
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in contrast to a non-transformed human mammary epithelial 
cell line that did not signiﬁ cantly metabolise genistein 
nor biochanin A [16]. This is also in contradiction to the 
ﬁ ndings by Nagel et al. (1998), who found no metabolism 
of genistein and equol after incubation with MCF-7 cells in 
serum-free medium for 18 h [14]. However, they did observe 
signiﬁ cant metabolism of coumestrol (15% recovery) under 
the same conditions, in addition to pronounced metabolism 
of genistein and coumestrol in serum-containing medium 
(53% and 68%, respectively). Furthermore, enterolactone has 
been found to be rapidly sulphated by both MCF-7 human 
breast cancer cells and HepG2 human liver cancer cells, and 
the monosulphate was the predominant metabolite in these 
cell cultures [17]. Therefore, it is possible that the reduced 
concentrations of genistein and, possibly, also of equol and 
daidzein, found in the medium in some of the experiments, is 
due not only to cellular uptake, but also to metabolism of the 
compounds. However, given the relatively short incubation 
times and the serum free conditions used, the contribution 
of biotransformation to the reduced recoveries is most likely 
limited.
The cellular uptake of genistein, daidzein, and equol was 
also investigated in murine adipocyte clusters. Adipose 
tissue is specialised connective tissue that functions as the 
major storage site for fat in the form of triglycerides. The 
adipocyte is one of the most metabolically active tissues in 
the human body, nearly tripling the blood circulation of any 
other organ. These cells are unique in comparison to any other 
cell type in the human body, and their hydrophobic nature 
renders investigation of the concentration of dietary estrogens 
interesting. Furthermore, in addition to xenoestrogens, it is 
known that tamoxifen accumulates to some extent in human 
breast fat tissue [18]. From the radioactive 17β-estradiol (E2) 
count, it is clear that E2 was taken up by the adipocyte clusters. 
In addition, the concentrations of soy-derived phytoestrogens 
in the medium were monitored over time, showing increasing 
cellular and decreasing media concentrations of both genistein 
and daidzein. Equol concentrations decreased in the medium 
for a period up to 270 min. Although equol was only detected 
at very low levels initially, it was found in the highest amounts 
in the adipocyte clusters at later time points. 
Finally, cellular uptake of soy-derived phytoestrogens was 
also studied in human blood fractions. It is generally known 
that cellular concentrations are better indicators of long-term 
dietary intake compared to serum concentrations (e.g. for 
vitamin C [19]). It is known that the half-lives of both genistein 
and daidzein are between 6-8 h, whereas, for equol, due to its 
intestinal microbial production from daidzein, the half-life 
approaches 24 h [20]. We therefore studied human sera and 
cellular fractions after soy isoﬂ avone intakes to establish the 
concentrations of genistein, daidzein, and equol. At 24 h 
after 0.5 l soymilk intake, some daidzein was still detected 
in serum; however, equol was found in both serum and cell 
fractions. This is consistent with the longer half-life of equol 
compared with the 2 isoﬂ avones. At 8 h after intake of 3 soy 
tablets (300 mg genistein/genistin, 111 mg daidzein/daidzin, 
45 mg glycitein/glycitin), both genistein and daidzein were 
found in the serum and cellular fraction, whereas the level of 
equol was much smaller. 
The combined results suggest that the uptake of soy-derived 
phytoestrogens into several cell types may be diﬀ erent 
depending on the nature of the compound. The observed 
diﬀ erences indicate the importance of detailed investigations 
of bioavailability and biodistribution in order to estimate 
possible eﬀ ects observed both in vitro and in vivo. The cellular 
uptake, and therefore the ability to elicit biological acitivities, 
may be somewhat higher for equol than for either genistein 
and daidzein. This may contribute to the health eﬀ ects due 
to soy intake observed in equol producers versus non-equol 
producers [21-26].
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